ronki23
Well-Known Member
Sinovac efficacy is 51% against symptomatic infection and 100% against severe Covid-19 14 days after receiving the second dose . Source: WHO
Sinopharm efficacy was 79% against symptomatic infection and 79% against hospitalisation. Source: WHO
Even if these vaccines aren't as strong as Pfizer (95% against symptomatic infection, 100% hospitalisation) or Moderna (94.5% efficacy, 100% hospitalisation) , on paper they are superior to Jannsen (66% efficacy against symptomatic infection, 100% hospitalisation) and Astra-Zeneca (76% against symptomatic infection, 100% hospitalisation).Source: Biospace
Shouldn't the Chinese have antibodies from exposure as well ?
Sinopharm efficacy was 79% against symptomatic infection and 79% against hospitalisation. Source: WHO
Even if these vaccines aren't as strong as Pfizer (95% against symptomatic infection, 100% hospitalisation) or Moderna (94.5% efficacy, 100% hospitalisation) , on paper they are superior to Jannsen (66% efficacy against symptomatic infection, 100% hospitalisation) and Astra-Zeneca (76% against symptomatic infection, 100% hospitalisation).Source: Biospace
Shouldn't the Chinese have antibodies from exposure as well ?
